Results 251 to 260 of about 81,923 (299)
Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review
Journal of the European Academy of Dermatology and Venereology, EarlyView.Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta +5 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Hand-Foot-Genital (Hand-Foot-Uterus) syndrome: Family report and update
American Journal of Medical Genetics Part A, 1988AbstractFour individuals from three generations of a family had the Hand‐Foot‐Genital (Hand‐Foot‐Uterus) syndrome. Affected females had urologic abnormalities confirming that the latter are part of the syndrome.
Fahed Halal
exaly +3 more sources
Management of hand-foot syndrome induced by capecitabine
Journal of Oncology Pharmacy Practice, 2006Introduction. Capecitabine (Xeloda®) is a systemic prodrug of 5-fluorouracil (5-FU), which is administered in an oral formulation. Hand-foot syndrome (HFS) has proven to be a chronic dose-limiting toxicity of capecitabine, leading to significant morbidity in patients receiving this agent.
Fred Hardwicke
exaly +3 more sources
The hand-foot syndrome in sickle-cell haemoglobinopathy
The Journal of Bone and Joint Surgery. British volume, 1995 The hand-foot syndrome is a benign self-limiting condition seen in young children with sickle-cell haemoglobinopathy, usually at the time of a crisis. The authors have observed 36 cases among 4920 patients. The features and management of the condition are discussed and the published literature is reviewed.
S S, Babhulkar, K, Pande, S, Babhulkar
openaire +3 more sources
Hand-foot-uterus- (HFU) syndrome with hypospadias: The hand-foot-genital- (HFG) syndrome
Pediatric Radiology, 1976Three brothers with the typical findings of the HFU-syndrome, but in addition with various degrees of hypospadias are reported. The family history otherwise was negative. The similarity of the "pattern-profile" of these cases with the mean pattern of the 11 previously reported ones is striking, as expressed by a product moment correlation of 0.83, 0.8 ...
A, Giedion, A, Prader
openaire +2 more sources
Hand-Foot and Stump Syndrome to Sorafenib
Journal of Clinical Oncology, 2007A 47-year-old white man, who had an above-the-knee amputation of his left leg, was treated with single-agent sorafenib 400 mg orally twice daily for metastatic renal cell carcinoma. The patient regularly wore a prosthesis that encases his left stump.
Susan E, Lai +2 more
openaire +2 more sources
Bone Scan in the Hand-Foot Syndrome
Clinical Nuclear Medicine, 1984The Hand-Foot Syndrome is a form of sickle cell disease that occurs in infancy. A bone scan performed on such a patient showed evidence of infarction in the hand. This was useful in the management of the patient.
L, Silver, R, Sarreck
openaire +2 more sources
Capecitabine and hand–foot syndrome
Expert Opinion on Drug Safety, 2010Hand-foot syndrome (HFS), or palmar-plantar erythrodysesthesia, is a common side effect in patients taking long-term 5-fluorouracil treatment and is the most frequently reported side effect of oral capecitabine therapy (≥ 50% of patients). Although the pathogenesis of HFS is not fully understood, it may be due to damaged deep capillaries in the soles ...
openaire +2 more sources
Capecitabine and Hand-foot Syndrome: A Case Report
Infectious Disorders - Drug Targets, 2023Abstract: Capecitabine, a prodrug of 5-fluorouracil, is an FDA-approved drug for adjuvant treatment of colon, metastatic colorectal, and breast cancer. A variety of mucocutaneous adverse effects has been recognized with capecitabine. The pathogenesis of such manifestations still remains an enigma though various theories have been proposed.
Praveen Kumar, Uppala +5 more
openaire +2 more sources